(Q35544987)

English

Potential Role of Endogenous and Exogenous Amyloid-Beta Binding Molecules in the Pathogenesis, Diagnosis, and Treatment of Alzheimer Disease

scientific article published on July 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Potential Role of Endogenous and Exogenous Amyloid-Beta Binding Molecules in the Pathogenesis, Diagnosis, and Treatment of Alzheimer Disease (English)

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Alzheimer's disease

0 references

David M. Holtzman

1

object named as

David M Holtzman

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

http://journals.lww.com/00002093-200307000-00006

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Alzheimer Disease and Associated Disorders

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

151-153

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

2

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.

4

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

5

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

6

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

7

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

8

1 reference

10.1097/00002093-200307000-00006

https://api.crossref.org/works/10.1097/00002093-200307000-00006

15 March 2024

Identifiers

10.1097/00002093-200307000-00006

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35544987&oldid=2102228712"